{
    "organizations": [],
    "uuid": "4319b9e30474daeb0ffe83423691b820904b9f7b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cleveland-biolabs-says-received-fo/brief-cleveland-biolabs-says-received-formal-notification-from-ema-idUSFWN1RA0W9",
    "ord_in_thread": 0,
    "title": "BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Cleveland Biolabs Inc:\n* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD\n* CLEVELAND BIOLABS - RECEIVED FORMAL NOTIFICATION FROM EMA THAT RESPONSES SHOULD BE SUBMITTED TO AGENCY BY SEPT 14 Source text - bit.ly/2pNGoDb Further company coverage:\n ",
    "published": "2018-03-29T01:07:00.000+03:00",
    "crawled": "2018-03-29T01:37:23.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cleveland",
        "biolabs",
        "inc",
        "cleveland",
        "biolabs",
        "received",
        "day",
        "review",
        "question",
        "ema",
        "regarding",
        "marketing",
        "authorization",
        "application",
        "entolimod",
        "cleveland",
        "biolabs",
        "received",
        "formal",
        "notification",
        "ema",
        "response",
        "submitted",
        "agency",
        "sept",
        "source",
        "text",
        "company",
        "coverage"
    ]
}